Global Celiac Disease Treatment Market – Industry Trends and Forecast to 2030

Celiac Disease Treatment Market Analysis and Size

Celiac disease is a type of genetic, auto-immune disorder which affects the small intestine upon consumption of gluten. It may also contribute to numerous diseases and disorders such as low bone density, neurological disorders, infertility, and certain cancers. There are no drugs available which can treat celiac diseases. The symptoms of the disease include loss of bone density, abdominal pain, headache, and weight loss. If left untreated, it leads to neurological dysfunction, infertility, osteoporosis, and anemia.                        

Data Bridge Market Research analyses that the global celiac disease treatment market which was USD 795.00 million in 2022, expected to reach USD 1,598.73 million by 2030, and is expected to undergo a CAGR of 10.84% during the forecast period 2023-2030. “Vitamins and dietary supplements” dominates the type segment of the celiac disease treatment market owing to the increasing penetration of the therapeutic products. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Celiac Disease Treatment Market Scope and Segmentation

Market Definition

Celiac disease, commonly known as celiac disease, is a chronic autoimmune condition of the small intestine. It is caused by consuming gluten, a protein present in wheat, barley, and rye. When people with celiac disease consume gluten, their immune system reacts by destroying the lining of their small intestine, resulting in a variety of digestive symptoms and potential nutrient shortages. The primary treatment for celiac disease is a gluten-free diet for life. This entails totally eliminating gluten-containing meals and beverages.

Celiac Disease Treatment Market Dynamics

Drivers

• Increasing Prevalence of Celiac Diseases

Celiac disease has become more widely recognised and diagnosed in recent years, resulting in an increase in the patient population. Because of the rising prevalence, there is a greater need for effective diagnostic techniques, drugs, and nutritional options to manage the illness. Thus increase in the incidence rates of celiac diseases is acting as driver for the market growth.

• Rising Public Awareness for Early Diagnosis 

Greater public and professional awareness of celiac disease symptoms, risk factors, and the necessity of early diagnosis has resulted in a rise in the number of persons seeking medical attention and receiving a proper diagnosis. As a result, the need for celiac disease treatment alternatives grows.

• Growing Gluten- Free Food Industry

Gluten-free products are in high demand due to the rising frequency of celiac disease and gluten sensitivity. As a result, the gluten-free food business has grown tremendously, offering a diverse selection of gluten-free options. This expansion in the gluten-free food business benefits the celiac disease treatment market indirectly.

Opportunities

• Rising Advancements in Diagnostic Approaches

Diagnostic technology advancements, like as serologic testing and genetic testing, have increased the accuracy and speed of celiac disease detection. These developments aid in early detection, allowing for fast treatment commencement and driving market growth.

• Rising Research Activities

Ongoing research & development efforts to better understand celiac disease and create novel treatment options are critical in propelling the market ahead. The development of novel therapeutic techniques, such as enzyme supplements, immune-modulating medicines, and possible vaccinations, has the potential to completely transform celiac disease management.

• Growing Healthcare Expenditure

The overall increase in healthcare spending, particularly in areas where celiac disease is more prevalent, offers the resources needed to improve diagnostic capabilities, treatment options, and patient care. Increased investment in healthcare infrastructure and services helps the celiac disease treatment industry flourish.

Restrains/ Challenges

• Limited Awareness and Underdiagnoses

Despite growing public awareness, celiac disease remains underdiagnosed or misdiagnosed. A lack of information among healthcare professionals and the general public can result in delayed diagnosis, undue pain, and long-term repercussions. Improving celiac disease awareness and information among healthcare practitioners and the general population remains a concern.

• Compliance with Gluten Free Diet

Due to the prevalence of gluten in many food products, adhering to a gluten-free diet can be difficult. Cross-contamination during meal preparation and dining out raises the danger of unintended gluten ingestion even higher. Maintaining a gluten-free diet takes extensive information, awareness, and lifestyle changes, which can be difficult for individuals, particularly in social settings or locations with limited availability to gluten-free foods.

• Limited Treatment Options

Currently, the primary treatment for celiac disease is a gluten-free diet. While it is successful for many patients, adhering to the diet can be difficult, and some people may experience ongoing symptoms even after adhering to the diet. While research is ongoing, there is currently no authorised pharmaceutical treatment for celiac disease that precisely targets the autoimmune response. The lack of pharmaceutical therapies beyond symptomatic alleviation and absence of alternative therapeutic options other than dietary changes may hinder market growth.

• High Cost of Gluten Free Products

Gluten-free products are frequently more expensive than gluten-containing alternatives. The financial burden of adhering to a gluten-free diet can be difficult for individuals, particularly in areas with limited access to affordable gluten-free options. This cost barrier may have an impact on the demand for gluten-free products and therapies.

This global celiac disease treatment market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the celiac disease treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Celiac Disease Treatment Market Scope

Global celiac disease treatment market is segmented on the basis of type, end-user, drugs, enzyme type and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

Type

• Vitamins and Dietary Supplements
• Steroids and Immunosuppressive Drugs
• Therapeutic Vaccines

End User

• Hospitals and Clinics
• Clinical Research Organisations
• Research and Academic Institutes

Drugs

• First Line of Treatment
• Second Line of Treatment

Enzyme Type

• Distension
• Diarrhoea
• Anorexia
• Bloating
• Gas
• Fatigue
• Others

Distribution Channel

• Hospitals
• Research centres
• Clinics
• Others

Global Celiac Disease Treatment Market Regional Analysis/Insights

Global celiac disease treatment market is analysed and market size insights and trends are provided by country, type, end-user, drugs, enzyme type and distribution channel as referenced above.

The countries covered in the global celiac disease treatment market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the global celiac disease treatment market due to increase in demand for advance treatment, rising health care expenditure, and high diagnosis rate in this region. Europe and

Asia-Pacific are the expected regions in terms of growth in global celiac disease treatment market due to increased government expenditure along with patient awareness and patient pool for celiac disease in this region.

The country section of the global celiac disease treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed base and New Technology Penetration

Global celiac disease treatment market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for global celiac disease treatment market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the celiac disease treatment market. The data is available for historic period 2015 to 2020.

Competitive Landscape and Global Celiac Disease Treatment Market Share Analysis

Global celiac disease treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to global celiac disease treatment market.

Some of the major players operating in the global celiac disease treatment market are:

• Amgen Inc. (U.S.)
• Amneal Pharmaceuticals LLC (U.S.)
• BioLineRx Ltd. (Israel)
• Calypso Biotech (Switzerland)
• FREEDOM FOODS GROUP LIMITED (Australia)
• General Mills Inc. (U.S.)
• Glenmark Pharmaceuticals (India)
• Hain Celestial (U.S.)
• 9 Meters Biopharma Inc. (U.S.)
• Kellogg Co (U.S.)
• Mondelez International (U.S.)
• Mylan N.V. (U.S.)
• Pinnacle Foods Inc (U.S.)
• Selecta Biosciences, Inc (U.S.)
• Takeda Pharmaceutical Company Limited (Japan)
• The Kraft Heinz Company (U.S.)
• Hikma Pharmaceuticals PLC (U.K.)
• ZEDIRA GmbH (Germany)

SKU-58828